EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;34:67-72. doi:10.1016/j.ejcts.2008.03.054
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Herko Grubitzsch
Wolfgang Konertz
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grubitzsch, H.
Right arrow Articles by Konertz, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Grubitzsch, H.
Right arrow Articles by Konertz, W.
Related Collections
Right arrow Coronary disease
Right arrow Electrophysiology - arrhythmias
Right arrow Valve disease

Factors predicting the time until atrial fibrillation recurrence after concomitant left atrial ablation

Herko Grubitzscha,*, Christian Grabowa, Helmut Orawab, Wolfgang Konertza

a Department of Cardiovascular Surgery, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany
b Department of Biostatistics and Clinical Epidemiology, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany

Received 1 December 2007; received in revised form 29 March 2008; accepted 31 March 2008.

* Corresponding author. Address: Klinik für Kardiovaskuläre Chirurgie, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Charité-Platz 1, 10117 Berlin, Germany. Tel.: +49 30 450522092; fax: +49 30 450522921. (Email: herko.grubitzsch{at}charite.de).

Objective: Treatment of atrial fibrillation, a risk factor for morbidity and mortality, by left atrial ablation is a less complex procedure which is increasingly performed in conjunction with surgery for various heart diseases. Although restoration of sinus rhythm is effective initially, atrial fibrillation may recur. We investigated factors predicting the time until its recurrence. Methods: Between January 2003 and December 2005, 162 consecutive patients (52.5% male, age 69 ± 8.7 years) with permanent atrial fibrillation underwent concomitant left atrial ablation and isolated or combined mitral valve surgery (42.6%), isolated or combined aortic valve surgery (32.1%), and isolated or combined coronary artery bypass grafting (24.1%). Ablation was performed by microwave (n = 93, 57.4%) or radiofrequency (n = 69, 42.6%) technology. Follow-up was after 3, 6, 12 months and yearly thereafter. Predictive values of variables for postoperative atrial fibrillation were examined using techniques of univariate and multivariate survival analysis (proportional hazards regression). Results: Eight patients died perioperatively and 13 during follow-up (not ablation related). Two patients were lost to follow-up. At last follow-up (19 ± 11.3 months), 86 patients (62%) were in stable sinus rhythm, 73 (52%) without antiarrhythmic drugs, and 43 (31%) were in atrial fibrillation. Predictors for the time until recurrence of atrial fibrillation in a multivariate model were preoperative atrial fibrillation duration (hazard ratio 1.005, 95% confidence interval 1.003–1.007, p < 0.001) and left atrial diameter (hazard ratio 1.056, 95% confidence interval 1.020–1.093, p = 0.002). Overall, sinus rhythm conversion rate was 75% when preoperative atrial fibrillation duration was less than 2 years, but 42% in longer lasting atrial fibrillation with left atrial dilatation (>50 mm). Age, gender, primary heart disease, history of thromboembolism or cardioversion, presence of concomitant diseases, EuroScore, left ventricular size and function, aortic cross-clamp time, ablation technology, and treatment with antiarrhythmic drugs did not predict rhythm outcome. Conclusions: Preoperative atrial fibrillation duration and left atrial diameter predict the time until atrial fibrillation recurrence after concomitant left atrial ablation, whereas age, type of primary cardiac surgery, ablation technology and antiarrhythmic therapy do not.

Key Words: Atrial fibrillation • Ablative therapy • Valvular surgery • Coronary artery bypass grafting







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.